It also investigates the effect of RG7388 or Nutlin-3 in combination with cisplatin in wild-type TP53 ovarian cancer cell lines and explores the mechanistic basis for the growth inhibitory and cytotoxic responses. Here, TP53 is linked to ovarian cancer.